Andreas Berg Sellevold

Great presentation by NEXAF PhD-candidate @KristofferRJ89 at the #ESCPrev2024 Atrial Fibrillation associated with ⬆️ mortality in endurance athletes. But absolute risk much lower compared to non-athletes. ➡️ Management of CV risk factors important in athletes with AF

Bærum hospital 🇳🇴 is the first site to reach 30 included athletes in The NEXAF Detraining Study on effects of reduced exercise intensity on AF burden in endurance athletes - congratulations @MariusMyrstad @TuridApelland Still including at all sites! 🇦🇨🇧🇪

Fantastic presentation by ⁦@MariusMyrstad⁩ on the temporal association between exercise and #Afib in athletes👏#sportscardiology #ESCCongress

This is a great study with very nice collaboration accross three countries 🇳🇴🇦🇺🇧🇪. Happy to the study running also in Belgium! NEXAF Detraining is the first ever RCT on effects of training intensity adaption on arrythmias in athletes: bmjopensem.bmj.com/content/9/2/e0… @Open_HeartBMJ

First 🇧🇪 athlete has been included in the NEXAF Detraining study. Cyclists and other athletes with atrial fibrillation are included at four hospitals in Belgium @UZLeuven @UZAnieuws @azJanPalfijn @JessaZiekenhuis @BELCycling Athletes can get in touch here: nexaf.no/nexaf-research…

Superb talk on the beneficial impact of #EXERCISE in preventing/treating #ATRIAL #FIBRILLATION by @JonMagne at the exercise medicine meeting at #NORWEGIAN #UNI OF #SCIENCE and #TECHNOLOGY